Barclays Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)
Hospital Business Recovery to Aid Haemonetics' (HAE) Q1 Earnings
Unveiling Teva Pharmaceutical Industries (TEVA) Q2 Outlook: Wall Street Estimates for Key Metrics
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
Unusual Options Activity: MMM, TEVA and Others Attract Market Bets, MMM V/OI Ratio Reaches 114.2
Sanofi, Teva Pharmaceuticals Expect Topline Results From Phase 2b Duvakitug Trial in Q4
Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients With Inflammatory Bowel Disease
Why Hims & Hers Heath Shares Are Surging Today
Hims & Hers Appoints Former Novo Nordisk President to Board
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
TEVA's Ajovy Meets Goal in Migraine Prevention Study for Kids
Teva's Migraine Treatment Found Effective For Children As Young As 6
Teva Pharmaceutical Says Trial of Ajovy to Prevent Episodic Migraine in Children Reaches Primary Endpoint
Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP Monoclonal Antibody in Children in AJOVY (Fremanezumab) SPACE Trial for Prevention of Episodic Migraine
Teva Pharmaceutical Industries (NYSE:TEVA) Climbs 5.3% This Week, Taking Five-year Gains to 117%
Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
Here's How Much $1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today
Express News | MediWound Files Amendment To Settlement Agreement With Teva; Under Amendment, Co Will Prepay Teva $4M As Final Payment Due From Company Under Agreement; 50% Of Prepayment In Cash, 50% In Form Of Ordinary Shares Of Co To Be Issued By Co To Teva
Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $20
UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $24